Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries.
Ann LevinColleen BurgessStephanie ShendaleWinthrop MorganRaymond C W Hutubessynull nullMark Jitnull nullPublished in: BMJ global health (2023)
The Intensified Investment scenario is likely the most cost-effective of the vaccination scenarios evaluated for reaching both measles and rubella disease elimination. Some data gaps on costs of increasing coverage were identified and future efforts should focus on filling these gaps.